| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasmodium falciparum | 182 | 2024 | 1741 | 15.220 |
Why?
|
| Malaria, Falciparum | 102 | 2024 | 1075 | 9.860 |
Why?
|
| Antimalarials | 88 | 2024 | 908 | 8.570 |
Why?
|
| Protozoan Proteins | 67 | 2024 | 844 | 6.160 |
Why?
|
| Drug Resistance | 67 | 2024 | 1595 | 5.570 |
Why?
|
| Malaria | 44 | 2024 | 1241 | 4.000 |
Why?
|
| Genome, Protozoan | 22 | 2024 | 153 | 3.550 |
Why?
|
| Chloroquine | 24 | 2017 | 275 | 3.170 |
Why?
|
| DNA, Protozoan | 46 | 2020 | 228 | 2.770 |
Why?
|
| Genes, Protozoan | 32 | 2024 | 170 | 2.290 |
Why?
|
| Artemisinins | 12 | 2020 | 217 | 2.040 |
Why?
|
| Plasmodium vivax | 16 | 2020 | 202 | 1.790 |
Why?
|
| Antigens, Protozoan | 15 | 2021 | 315 | 1.710 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 8 | 2023 | 173 | 1.680 |
Why?
|
| Senegal | 35 | 2024 | 255 | 1.620 |
Why?
|
| Plasmodium | 20 | 2022 | 248 | 1.550 |
Why?
|
| Parasites | 8 | 2023 | 160 | 1.450 |
Why?
|
| Anopheles | 11 | 2022 | 193 | 1.400 |
Why?
|
| Malaria Vaccines | 6 | 2024 | 164 | 1.320 |
Why?
|
| ATP-Binding Cassette Transporters | 15 | 2021 | 567 | 1.300 |
Why?
|
| Drug Discovery | 9 | 2021 | 1067 | 1.220 |
Why?
|
| RNA, Protozoan | 12 | 2015 | 46 | 1.180 |
Why?
|
| Leishmania | 18 | 1995 | 75 | 1.130 |
Why?
|
| Enzyme Inhibitors | 11 | 2021 | 3722 | 1.090 |
Why?
|
| Plasmodium gallinaceum | 7 | 2003 | 8 | 1.050 |
Why?
|
| Microfilament Proteins | 3 | 2020 | 1135 | 1.040 |
Why?
|
| Genetic Variation | 28 | 2020 | 6606 | 1.000 |
Why?
|
| Selection, Genetic | 13 | 2019 | 877 | 0.990 |
Why?
|
| Leishmania mexicana | 11 | 2004 | 33 | 0.970 |
Why?
|
| Antibodies, Protozoan | 5 | 2021 | 251 | 0.940 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 6 | 2021 | 133 | 0.930 |
Why?
|
| Malaria, Vivax | 9 | 2020 | 166 | 0.900 |
Why?
|
| Base Sequence | 60 | 2019 | 12422 | 0.830 |
Why?
|
| Plasmodium berghei | 7 | 2017 | 161 | 0.810 |
Why?
|
| 4-Butyrolactone | 2 | 2019 | 59 | 0.780 |
Why?
|
| Polymorphism, Single Nucleotide | 31 | 2024 | 16028 | 0.770 |
Why?
|
| DNA Probes | 14 | 1994 | 542 | 0.770 |
Why?
|
| Drug Resistance, Multiple | 11 | 2024 | 255 | 0.770 |
Why?
|
| Erythrocytes | 12 | 2019 | 2421 | 0.760 |
Why?
|
| Parasitic Sensitivity Tests | 16 | 2021 | 90 | 0.700 |
Why?
|
| Dihydropteroate Synthase | 5 | 2021 | 27 | 0.690 |
Why?
|
| Animals | 187 | 2023 | 169337 | 0.690 |
Why?
|
| Transcription, Genetic | 25 | 2012 | 7599 | 0.680 |
Why?
|
| Membrane Transport Proteins | 13 | 2024 | 1034 | 0.670 |
Why?
|
| Gene Expression Regulation | 17 | 2018 | 11918 | 0.660 |
Why?
|
| Pneumonia, Bacterial | 2 | 2021 | 319 | 0.650 |
Why?
|
| Gene Expression Profiling | 10 | 2017 | 9510 | 0.630 |
Why?
|
| Molecular Sequence Data | 55 | 2015 | 17626 | 0.630 |
Why?
|
| Parasitemia | 8 | 2019 | 165 | 0.620 |
Why?
|
| Microsatellite Repeats | 8 | 2014 | 784 | 0.620 |
Why?
|
| Recombination, Genetic | 5 | 2018 | 1526 | 0.620 |
Why?
|
| Genes, MDR | 4 | 2008 | 36 | 0.620 |
Why?
|
| Polymorphism, Genetic | 14 | 2021 | 4250 | 0.610 |
Why?
|
| Polymerase Chain Reaction | 36 | 2021 | 6085 | 0.600 |
Why?
|
| Mutation | 27 | 2024 | 30228 | 0.590 |
Why?
|
| Cytochromes b | 3 | 2016 | 35 | 0.580 |
Why?
|
| Infectious Disease Medicine | 1 | 2018 | 49 | 0.580 |
Why?
|
| Tropical Medicine | 1 | 2018 | 52 | 0.580 |
Why?
|
| Drug Evaluation, Preclinical | 11 | 2019 | 1339 | 0.570 |
Why?
|
| Amino Acyl-tRNA Synthetases | 4 | 2022 | 88 | 0.550 |
Why?
|
| Genotype | 31 | 2024 | 13042 | 0.540 |
Why?
|
| Transgenes | 2 | 2010 | 1015 | 0.540 |
Why?
|
| Models, Genetic | 8 | 2018 | 3442 | 0.530 |
Why?
|
| Meiosis | 1 | 2018 | 327 | 0.510 |
Why?
|
| DNA Barcoding, Taxonomic | 7 | 2020 | 134 | 0.500 |
Why?
|
| Virus Diseases | 1 | 2021 | 723 | 0.500 |
Why?
|
| Genetics, Population | 5 | 2018 | 942 | 0.500 |
Why?
|
| Leishmaniasis | 6 | 2004 | 67 | 0.490 |
Why?
|
| Chromosomes | 5 | 2011 | 579 | 0.490 |
Why?
|
| Hemeproteins | 2 | 2019 | 61 | 0.490 |
Why?
|
| Retroviridae | 3 | 2010 | 849 | 0.480 |
Why?
|
| Pyrimethamine | 5 | 2021 | 94 | 0.480 |
Why?
|
| Mefloquine | 9 | 2013 | 55 | 0.480 |
Why?
|
| Gene Targeting | 3 | 2010 | 841 | 0.480 |
Why?
|
| Leishmania enriettii | 3 | 2004 | 3 | 0.470 |
Why?
|
| Tubulin | 13 | 1994 | 695 | 0.460 |
Why?
|
| Malaria, Cerebral | 2 | 2015 | 136 | 0.460 |
Why?
|
| RNA, Antisense | 2 | 2005 | 136 | 0.460 |
Why?
|
| Membrane Proteins | 14 | 2013 | 7880 | 0.460 |
Why?
|
| Point Mutation | 9 | 2019 | 1594 | 0.450 |
Why?
|
| Pathology, Molecular | 1 | 2017 | 329 | 0.440 |
Why?
|
| Sulfadoxine | 4 | 2021 | 46 | 0.440 |
Why?
|
| Automation, Laboratory | 1 | 2014 | 102 | 0.440 |
Why?
|
| Nucleic Acid Hybridization | 30 | 2011 | 1305 | 0.430 |
Why?
|
| Luciferases | 8 | 2010 | 712 | 0.430 |
Why?
|
| DNA, Circular | 7 | 1994 | 97 | 0.420 |
Why?
|
| 5' Untranslated Regions | 4 | 2004 | 255 | 0.420 |
Why?
|
| Insect Vectors | 8 | 2011 | 136 | 0.420 |
Why?
|
| Research | 3 | 2011 | 1981 | 0.420 |
Why?
|
| Chemistry, Pharmaceutical | 3 | 2014 | 275 | 0.420 |
Why?
|
| Protein Sorting Signals | 4 | 2000 | 274 | 0.410 |
Why?
|
| Genetic Fitness | 1 | 2013 | 120 | 0.410 |
Why?
|
| Communicable Disease Control | 3 | 2014 | 857 | 0.400 |
Why?
|
| Transfection | 13 | 2007 | 5764 | 0.400 |
Why?
|
| Sri Lanka | 7 | 2020 | 93 | 0.400 |
Why?
|
| Evolution, Molecular | 7 | 2018 | 1893 | 0.390 |
Why?
|
| Linkage Disequilibrium | 11 | 2018 | 1998 | 0.380 |
Why?
|
| Genetic Loci | 7 | 2016 | 2630 | 0.380 |
Why?
|
| Polymorphism, Restriction Fragment Length | 8 | 2017 | 767 | 0.370 |
Why?
|
| Genetic Vectors | 8 | 2010 | 3413 | 0.370 |
Why?
|
| Quinazolinones | 5 | 2022 | 219 | 0.370 |
Why?
|
| Indoles | 5 | 2015 | 1825 | 0.370 |
Why?
|
| Host-Parasite Interactions | 6 | 2018 | 303 | 0.370 |
Why?
|
| Amodiaquine | 2 | 2008 | 58 | 0.370 |
Why?
|
| Genomics | 5 | 2022 | 5916 | 0.370 |
Why?
|
| Sequence Analysis, DNA | 12 | 2021 | 4775 | 0.360 |
Why?
|
| Quinolines | 4 | 2021 | 768 | 0.350 |
Why?
|
| Entamoeba histolytica | 6 | 1994 | 28 | 0.350 |
Why?
|
| Blotting, Southern | 12 | 2006 | 777 | 0.340 |
Why?
|
| Virus Assembly | 1 | 2010 | 141 | 0.340 |
Why?
|
| Mitochondria | 5 | 2018 | 3675 | 0.340 |
Why?
|
| DNA | 23 | 1992 | 7211 | 0.340 |
Why?
|
| Gene Expression | 13 | 2013 | 7598 | 0.330 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2022 | 2676 | 0.330 |
Why?
|
| Humans | 159 | 2024 | 768393 | 0.330 |
Why?
|
| Biological Evolution | 2 | 2014 | 1078 | 0.330 |
Why?
|
| Haplotypes | 11 | 2024 | 2724 | 0.320 |
Why?
|
| Cloning, Molecular | 22 | 1993 | 4168 | 0.320 |
Why?
|
| Life Cycle Stages | 4 | 2016 | 161 | 0.320 |
Why?
|
| NADH Dehydrogenase | 1 | 2008 | 47 | 0.320 |
Why?
|
| Heme | 2 | 2021 | 316 | 0.320 |
Why?
|
| Fluorenes | 4 | 2016 | 160 | 0.310 |
Why?
|
| Colorimetry | 1 | 2009 | 151 | 0.310 |
Why?
|
| Leadership | 1 | 2018 | 1395 | 0.300 |
Why?
|
| Genes | 12 | 2001 | 1824 | 0.300 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 11 | 2013 | 3794 | 0.300 |
Why?
|
| Piperidines | 6 | 2022 | 1659 | 0.300 |
Why?
|
| Electron Transport | 1 | 2008 | 211 | 0.300 |
Why?
|
| Parasitology | 3 | 2018 | 28 | 0.300 |
Why?
|
| Chromosome Mapping | 11 | 2015 | 4622 | 0.300 |
Why?
|
| RNA, Messenger | 24 | 2009 | 12805 | 0.290 |
Why?
|
| Orotic Acid | 1 | 2007 | 24 | 0.290 |
Why?
|
| Expressed Sequence Tags | 3 | 2004 | 250 | 0.290 |
Why?
|
| Plasmodium ovale | 2 | 2017 | 13 | 0.280 |
Why?
|
| Gene Amplification | 14 | 2009 | 1090 | 0.280 |
Why?
|
| Ethanolamines | 4 | 2016 | 153 | 0.270 |
Why?
|
| Genes, Reporter | 4 | 2004 | 1524 | 0.270 |
Why?
|
| Coenzyme A Ligases | 1 | 2006 | 45 | 0.270 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2018 | 308 | 0.270 |
Why?
|
| Plasmids | 17 | 2001 | 2268 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2021 | 3241 | 0.260 |
Why?
|
| RNA, Ribosomal | 8 | 2004 | 227 | 0.260 |
Why?
|
| Pneumonia | 2 | 2017 | 2163 | 0.260 |
Why?
|
| Directed Molecular Evolution | 2 | 2024 | 165 | 0.250 |
Why?
|
| Blotting, Northern | 7 | 2007 | 1553 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 6 | 2012 | 5801 | 0.250 |
Why?
|
| Antiparasitic Agents | 1 | 2005 | 42 | 0.250 |
Why?
|
| International Cooperation | 1 | 2011 | 1438 | 0.240 |
Why?
|
| Species Specificity | 14 | 2011 | 2417 | 0.240 |
Why?
|
| Glucose | 1 | 2016 | 4352 | 0.240 |
Why?
|
| Small Molecule Libraries | 4 | 2014 | 742 | 0.230 |
Why?
|
| Drug Resistance, Microbial | 7 | 2015 | 830 | 0.230 |
Why?
|
| Structure-Activity Relationship | 9 | 2016 | 3055 | 0.230 |
Why?
|
| DNA Mismatch Repair | 1 | 2007 | 433 | 0.220 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2004 | 792 | 0.220 |
Why?
|
| Superinfection | 1 | 2024 | 63 | 0.220 |
Why?
|
| Drug Design | 5 | 2018 | 1046 | 0.220 |
Why?
|
| Gene Dosage | 4 | 2018 | 1221 | 0.220 |
Why?
|
| Child, Preschool | 28 | 2022 | 42650 | 0.220 |
Why?
|
| Cell Line | 10 | 2010 | 15597 | 0.220 |
Why?
|
| Gene Frequency | 8 | 2018 | 3617 | 0.220 |
Why?
|
| High-Throughput Screening Assays | 5 | 2019 | 937 | 0.210 |
Why?
|
| Amino Acid Sequence | 20 | 2018 | 13423 | 0.210 |
Why?
|
| Vinblastine | 5 | 2004 | 488 | 0.210 |
Why?
|
| Disease Outbreaks | 4 | 2014 | 1762 | 0.210 |
Why?
|
| Escherichia coli Proteins | 1 | 2009 | 1057 | 0.210 |
Why?
|
| Amebiasis | 2 | 2000 | 33 | 0.200 |
Why?
|
| Africa | 4 | 2015 | 726 | 0.200 |
Why?
|
| Cluster Analysis | 6 | 2022 | 2728 | 0.200 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2001 | 14 | 0.200 |
Why?
|
| Child | 33 | 2022 | 80891 | 0.200 |
Why?
|
| Nigeria | 10 | 2021 | 779 | 0.200 |
Why?
|
| Culicidae | 5 | 2018 | 110 | 0.190 |
Why?
|
| Acetate-CoA Ligase | 1 | 2021 | 9 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2015 | 3612 | 0.190 |
Why?
|
| 3' Untranslated Regions | 2 | 2004 | 515 | 0.190 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2022 | 1836 | 0.190 |
Why?
|
| Ligases | 1 | 2023 | 333 | 0.190 |
Why?
|
| Triazoles | 2 | 2019 | 904 | 0.190 |
Why?
|
| Folic Acid Antagonists | 1 | 2021 | 74 | 0.190 |
Why?
|
| Oocysts | 2 | 2018 | 16 | 0.190 |
Why?
|
| Alleles | 10 | 2018 | 6892 | 0.190 |
Why?
|
| Infant | 21 | 2024 | 36510 | 0.190 |
Why?
|
| Multigene Family | 5 | 2018 | 1082 | 0.180 |
Why?
|
| Restriction Mapping | 8 | 1993 | 849 | 0.180 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2001 | 177 | 0.180 |
Why?
|
| Mutation, Missense | 5 | 2024 | 2593 | 0.180 |
Why?
|
| Sequence Alignment | 7 | 2011 | 2176 | 0.180 |
Why?
|
| Genetic Markers | 7 | 2015 | 2604 | 0.180 |
Why?
|
| RNA Polymerase II | 1 | 2005 | 547 | 0.180 |
Why?
|
| Multidrug Resistance-Associated Proteins | 3 | 2020 | 105 | 0.170 |
Why?
|
| Inhibitory Concentration 50 | 6 | 2015 | 466 | 0.170 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 329 | 0.170 |
Why?
|
| Mosquito Control | 2 | 2018 | 110 | 0.170 |
Why?
|
| Indians, South American | 1 | 1999 | 34 | 0.170 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2000 | 64 | 0.170 |
Why?
|
| Primaquine | 2 | 2017 | 28 | 0.170 |
Why?
|
| Pyrimidines | 3 | 2019 | 3048 | 0.170 |
Why?
|
| Models, Molecular | 6 | 2021 | 5404 | 0.170 |
Why?
|
| Quinolones | 2 | 2016 | 382 | 0.170 |
Why?
|
| Sequence Deletion | 3 | 2019 | 1497 | 0.170 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 8 | 2007 | 781 | 0.160 |
Why?
|
| Mycobacterium | 2 | 1991 | 252 | 0.160 |
Why?
|
| Genetic Techniques | 3 | 2018 | 428 | 0.160 |
Why?
|
| Onchocerca | 2 | 1989 | 3 | 0.160 |
Why?
|
| RNA Splicing | 5 | 2015 | 903 | 0.160 |
Why?
|
| Gene Deletion | 5 | 2006 | 2673 | 0.160 |
Why?
|
| Phenanthrenes | 3 | 2013 | 66 | 0.150 |
Why?
|
| Quinine | 3 | 2004 | 51 | 0.150 |
Why?
|
| Haploidy | 1 | 2018 | 127 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 2038 | 0.150 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2019 | 178 | 0.150 |
Why?
|
| Electrophoresis, Agar Gel | 7 | 1999 | 205 | 0.150 |
Why?
|
| Disease Transmission, Infectious | 3 | 2011 | 562 | 0.150 |
Why?
|
| Phylogeny | 4 | 2018 | 2843 | 0.150 |
Why?
|
| Lysophosphatidylcholines | 1 | 2017 | 77 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2007 | 4588 | 0.140 |
Why?
|
| Transition Temperature | 1 | 2017 | 33 | 0.140 |
Why?
|
| DNA Primers | 6 | 2005 | 2825 | 0.140 |
Why?
|
| RNA, Untranslated | 2 | 2011 | 457 | 0.140 |
Why?
|
| Extrachromosomal Inheritance | 3 | 1994 | 18 | 0.140 |
Why?
|
| Macrolides | 1 | 2018 | 205 | 0.140 |
Why?
|
| Proline | 1 | 2019 | 455 | 0.140 |
Why?
|
| Plasmodium malariae | 1 | 2017 | 13 | 0.140 |
Why?
|
| Gambia | 4 | 2019 | 104 | 0.140 |
Why?
|
| Quinazolines | 2 | 2015 | 1373 | 0.140 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2014 | 298 | 0.140 |
Why?
|
| DNA, Bacterial | 4 | 1993 | 1479 | 0.140 |
Why?
|
| Blood | 4 | 2015 | 597 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 4 | 2009 | 2069 | 0.130 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 611 | 0.130 |
Why?
|
| Chemoprevention | 1 | 2018 | 326 | 0.130 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2006 | 2750 | 0.130 |
Why?
|
| Bacterial Proteins | 1 | 2009 | 3838 | 0.130 |
Why?
|
| Mice, SCID | 2 | 2019 | 2632 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 3666 | 0.130 |
Why?
|
| Lactams, Macrocyclic | 2 | 2014 | 319 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 2003 | 1056 | 0.130 |
Why?
|
| Genes, Bacterial | 2 | 1990 | 1076 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 1209 | 0.130 |
Why?
|
| Toxoplasmosis | 1 | 2016 | 94 | 0.130 |
Why?
|
| Malawi | 3 | 2012 | 309 | 0.130 |
Why?
|
| Dysentery, Amebic | 2 | 1993 | 6 | 0.130 |
Why?
|
| Staff Development | 1 | 2018 | 230 | 0.130 |
Why?
|
| Female | 46 | 2024 | 397089 | 0.130 |
Why?
|
| Coordination Complexes | 1 | 2016 | 73 | 0.130 |
Why?
|
| Hepatocytes | 2 | 2018 | 1245 | 0.130 |
Why?
|
| DNA Copy Number Variations | 4 | 2023 | 2046 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2017 | 798 | 0.120 |
Why?
|
| Azetidines | 1 | 2016 | 143 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2017 | 620 | 0.120 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 839 | 0.120 |
Why?
|
| Adaptation, Biological | 1 | 2016 | 147 | 0.120 |
Why?
|
| Toxoplasma | 1 | 2016 | 159 | 0.120 |
Why?
|
| Molecular Structure | 5 | 2021 | 1884 | 0.120 |
Why?
|
| Burkina Faso | 3 | 2021 | 88 | 0.120 |
Why?
|
| Ficoll | 1 | 2014 | 39 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2000 | 2281 | 0.120 |
Why?
|
| Phenylurea Compounds | 2 | 2016 | 530 | 0.120 |
Why?
|
| Male | 38 | 2024 | 364902 | 0.120 |
Why?
|
| Brugia | 4 | 1987 | 24 | 0.120 |
Why?
|
| Genetic Complementation Test | 1 | 1995 | 557 | 0.120 |
Why?
|
| Gene Conversion | 2 | 2006 | 69 | 0.120 |
Why?
|
| Mutagenesis | 2 | 2003 | 1229 | 0.120 |
Why?
|
| Carrier Proteins | 5 | 2012 | 4936 | 0.120 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 1994 | 36 | 0.120 |
Why?
|
| Microscopy | 1 | 2019 | 909 | 0.120 |
Why?
|
| Drug Combinations | 5 | 2021 | 2079 | 0.120 |
Why?
|
| Polyvinyl Alcohol | 1 | 2014 | 74 | 0.120 |
Why?
|
| Glycoproteins | 4 | 1995 | 2204 | 0.120 |
Why?
|
| Biological Assay | 2 | 2008 | 627 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 501 | 0.120 |
Why?
|
| Emetine | 3 | 1990 | 15 | 0.120 |
Why?
|
| Reproduction | 3 | 2017 | 646 | 0.120 |
Why?
|
| Glycolysis | 2 | 2016 | 838 | 0.110 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2015 | 239 | 0.110 |
Why?
|
| Crystallization | 2 | 2019 | 521 | 0.110 |
Why?
|
| Genome | 3 | 2015 | 1747 | 0.110 |
Why?
|
| Genetic Drift | 1 | 2013 | 41 | 0.110 |
Why?
|
| Reticulocytes | 1 | 2014 | 288 | 0.110 |
Why?
|
| Biomedical Research | 2 | 2021 | 3464 | 0.110 |
Why?
|
| Leishmania major | 1 | 1993 | 60 | 0.110 |
Why?
|
| Genes, Regulator | 1 | 1994 | 373 | 0.110 |
Why?
|
| Drug Synergism | 2 | 2014 | 1762 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2009 | 775 | 0.110 |
Why?
|
| Cambodia | 3 | 2018 | 185 | 0.110 |
Why?
|
| Phenotype | 9 | 2019 | 16721 | 0.110 |
Why?
|
| Iron | 1 | 2002 | 1814 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1616 | 0.110 |
Why?
|
| Founder Effect | 1 | 2013 | 185 | 0.110 |
Why?
|
| Ubiquinone | 1 | 2014 | 183 | 0.110 |
Why?
|
| Markov Chains | 1 | 2017 | 977 | 0.110 |
Why?
|
| Amines | 2 | 2015 | 280 | 0.110 |
Why?
|
| Niacinamide | 1 | 2015 | 418 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2008 | 1742 | 0.100 |
Why?
|
| Adolescent | 20 | 2022 | 89184 | 0.100 |
Why?
|
| Cricetinae | 3 | 2009 | 2423 | 0.100 |
Why?
|
| Telomere | 2 | 2011 | 943 | 0.100 |
Why?
|
| Mice | 22 | 2019 | 82017 | 0.100 |
Why?
|
| Sensitivity and Specificity | 11 | 2019 | 14737 | 0.100 |
Why?
|
| Nitrogen | 1 | 2014 | 345 | 0.100 |
Why?
|
| Dextrans | 1 | 2014 | 574 | 0.100 |
Why?
|
| ABO Blood-Group System | 2 | 2012 | 381 | 0.100 |
Why?
|
| Liver | 4 | 2016 | 7574 | 0.100 |
Why?
|
| Merozoite Surface Protein 1 | 3 | 2021 | 36 | 0.100 |
Why?
|
| Caloric Restriction | 1 | 2015 | 300 | 0.100 |
Why?
|
| Probability | 1 | 2018 | 2482 | 0.100 |
Why?
|
| CHO Cells | 2 | 2009 | 1380 | 0.100 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2014 | 339 | 0.100 |
Why?
|
| Catalytic Domain | 1 | 2014 | 698 | 0.100 |
Why?
|
| Binding Sites | 5 | 2014 | 6017 | 0.100 |
Why?
|
| Thiazepines | 1 | 2011 | 30 | 0.100 |
Why?
|
| Electron Transport Complex III | 1 | 2011 | 31 | 0.100 |
Why?
|
| Prevalence | 11 | 2017 | 15872 | 0.100 |
Why?
|
| South America | 2 | 2015 | 180 | 0.100 |
Why?
|
| Computational Biology | 3 | 2015 | 3543 | 0.100 |
Why?
|
| Thailand | 4 | 1994 | 288 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2016 | 10776 | 0.100 |
Why?
|
| Endemic Diseases | 3 | 2017 | 190 | 0.100 |
Why?
|
| Genetic Linkage | 3 | 2013 | 2342 | 0.090 |
Why?
|
| Naphthyridines | 1 | 2013 | 181 | 0.090 |
Why?
|
| Treatment Failure | 4 | 2016 | 2663 | 0.090 |
Why?
|
| Molecular Typing | 1 | 2012 | 115 | 0.090 |
Why?
|
| Immunoassay | 2 | 2016 | 745 | 0.090 |
Why?
|
| Base Composition | 3 | 2012 | 291 | 0.090 |
Why?
|
| Kenya | 3 | 2024 | 757 | 0.090 |
Why?
|
| Genomic Library | 2 | 2001 | 188 | 0.090 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1993 | 706 | 0.090 |
Why?
|
| Atovaquone | 3 | 2022 | 56 | 0.090 |
Why?
|
| Hepatitis, Animal | 1 | 2010 | 19 | 0.090 |
Why?
|
| Silanes | 1 | 2010 | 28 | 0.090 |
Why?
|
| Fluorescent Dyes | 2 | 2010 | 1926 | 0.090 |
Why?
|
| Pseudogenes | 2 | 2011 | 104 | 0.090 |
Why?
|
| Leukemia Virus, Murine | 2 | 2002 | 95 | 0.090 |
Why?
|
| Mycobacterium Infections | 1 | 1991 | 122 | 0.090 |
Why?
|
| Gene Flow | 1 | 2010 | 79 | 0.090 |
Why?
|
| Mycobacterium avium | 1 | 1990 | 29 | 0.090 |
Why?
|
| Asia | 2 | 2015 | 627 | 0.090 |
Why?
|
| Ghana | 2 | 2024 | 319 | 0.090 |
Why?
|
| Myanmar | 1 | 2010 | 43 | 0.090 |
Why?
|
| Neomycin | 1 | 1990 | 94 | 0.090 |
Why?
|
| Protein Conformation | 3 | 2007 | 3955 | 0.090 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 1882 | 0.090 |
Why?
|
| Licensure | 1 | 2011 | 127 | 0.090 |
Why?
|
| Antiprotozoal Agents | 2 | 2004 | 95 | 0.090 |
Why?
|
| Pedigree | 1 | 2018 | 4544 | 0.090 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1989 | 221 | 0.080 |
Why?
|
| Cytochrome b Group | 1 | 1989 | 59 | 0.080 |
Why?
|
| Genes, Insect | 1 | 2010 | 265 | 0.080 |
Why?
|
| Spleen | 1 | 2016 | 2296 | 0.080 |
Why?
|
| Models, Chemical | 2 | 2008 | 611 | 0.080 |
Why?
|
| Invertebrate Hormones | 1 | 1989 | 24 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2014 | 1149 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 18362 | 0.080 |
Why?
|
| Leishmania donovani | 4 | 1993 | 68 | 0.080 |
Why?
|
| Gametogenesis | 1 | 2009 | 27 | 0.080 |
Why?
|
| Crystallography, X-Ray | 1 | 2014 | 1952 | 0.080 |
Why?
|
| Leishmaniavirus | 2 | 1999 | 3 | 0.080 |
Why?
|
| Indophenol | 1 | 2008 | 6 | 0.080 |
Why?
|
| Genes, Fungal | 2 | 2004 | 439 | 0.080 |
Why?
|
| Specimen Handling | 1 | 2014 | 708 | 0.080 |
Why?
|
| Vitamin K 3 | 1 | 2008 | 14 | 0.080 |
Why?
|
| Virulence Factors | 1 | 2012 | 502 | 0.080 |
Why?
|
| Onium Compounds | 1 | 2008 | 27 | 0.080 |
Why?
|
| Biological Products | 1 | 2018 | 934 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2014 | 864 | 0.080 |
Why?
|
| Phenol | 1 | 2008 | 44 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2001 | 1086 | 0.080 |
Why?
|
| Psychodidae | 1 | 1988 | 27 | 0.080 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 1195 | 0.080 |
Why?
|
| Bone Marrow | 2 | 2018 | 2929 | 0.080 |
Why?
|
| DNA, Kinetoplast | 4 | 1990 | 12 | 0.080 |
Why?
|
| Demography | 2 | 2012 | 1642 | 0.080 |
Why?
|
| Ovalbumin | 1 | 2010 | 677 | 0.080 |
Why?
|
| Molecular Epidemiology | 2 | 2022 | 473 | 0.080 |
Why?
|
| Membrane Glycoproteins | 4 | 1994 | 3712 | 0.080 |
Why?
|
| DNA Fingerprinting | 1 | 2008 | 114 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 1110 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 2225 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 2 | 1990 | 1929 | 0.080 |
Why?
|
| Interferon-gamma | 2 | 1993 | 3164 | 0.080 |
Why?
|
| Virus Integration | 1 | 2010 | 306 | 0.080 |
Why?
|
| Seasons | 4 | 2019 | 1526 | 0.080 |
Why?
|
| RNA, Small Nuclear | 1 | 1988 | 71 | 0.070 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 1238 | 0.070 |
Why?
|
| Integrases | 1 | 2010 | 520 | 0.070 |
Why?
|
| Sequence Analysis | 2 | 2001 | 240 | 0.070 |
Why?
|
| Cricetulus | 1 | 2009 | 813 | 0.070 |
Why?
|
| Ethiopia | 1 | 2010 | 482 | 0.070 |
Why?
|
| Public Health | 1 | 2021 | 2682 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2014 | 1575 | 0.070 |
Why?
|
| Drug Therapy, Combination | 3 | 2016 | 6318 | 0.070 |
Why?
|
| Proteome | 3 | 2017 | 1881 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 902 | 0.070 |
Why?
|
| Electrons | 1 | 2008 | 264 | 0.070 |
Why?
|
| Aotidae | 2 | 2018 | 57 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 3731 | 0.070 |
Why?
|
| Codon | 2 | 2006 | 599 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1468 | 0.070 |
Why?
|
| Proguanil | 1 | 2006 | 11 | 0.070 |
Why?
|
| Central America | 1 | 2006 | 69 | 0.070 |
Why?
|
| DNA Restriction Enzymes | 7 | 1987 | 548 | 0.070 |
Why?
|
| Genome-Wide Association Study | 3 | 2012 | 12778 | 0.070 |
Why?
|
| Zambia | 2 | 2020 | 273 | 0.070 |
Why?
|
| Immunization | 2 | 2008 | 1219 | 0.070 |
Why?
|
| Poly A | 2 | 2000 | 180 | 0.070 |
Why?
|
| Leptin | 1 | 2015 | 1597 | 0.070 |
Why?
|
| Open Reading Frames | 3 | 2011 | 812 | 0.070 |
Why?
|
| Naphthoquinones | 1 | 2006 | 59 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2018 | 6277 | 0.070 |
Why?
|
| Coculture Techniques | 1 | 2010 | 1342 | 0.070 |
Why?
|
| Electrophoresis, Capillary | 1 | 2006 | 63 | 0.070 |
Why?
|
| Rhodamine 123 | 2 | 2004 | 37 | 0.070 |
Why?
|
| DNA, Mitochondrial | 2 | 1989 | 871 | 0.070 |
Why?
|
| Immunization, Passive | 1 | 2008 | 619 | 0.070 |
Why?
|
| Adult | 22 | 2018 | 223640 | 0.070 |
Why?
|
| Cell Survival | 4 | 2018 | 5792 | 0.060 |
Why?
|
| Principal Component Analysis | 3 | 2015 | 948 | 0.060 |
Why?
|
| Chickens | 2 | 2001 | 845 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2014 | 2771 | 0.060 |
Why?
|
| Biological Transport | 2 | 2004 | 2085 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 2066 | 0.060 |
Why?
|
| Ribonucleoproteins | 1 | 1988 | 359 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2008 | 753 | 0.060 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 414 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2010 | 1081 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2016 | 2906 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2003 | 1368 | 0.060 |
Why?
|
| Germ Cells | 1 | 2009 | 643 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6241 | 0.060 |
Why?
|
| Gene Duplication | 1 | 2006 | 315 | 0.060 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2004 | 10 | 0.060 |
Why?
|
| Quinacrine | 1 | 2004 | 24 | 0.060 |
Why?
|
| Health Policy | 2 | 2011 | 2698 | 0.060 |
Why?
|
| Introns | 2 | 2001 | 968 | 0.060 |
Why?
|
| Quinidine | 1 | 2004 | 52 | 0.060 |
Why?
|
| Cycloheximide | 1 | 2004 | 342 | 0.060 |
Why?
|
| Models, Animal | 1 | 2010 | 2124 | 0.060 |
Why?
|
| Verapamil | 3 | 1995 | 242 | 0.060 |
Why?
|
| DNA, Ribosomal | 4 | 1987 | 301 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2000 | 2475 | 0.060 |
Why?
|
| Sindbis Virus | 3 | 1980 | 36 | 0.060 |
Why?
|
| Fluoresceins | 1 | 2004 | 235 | 0.060 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 14784 | 0.060 |
Why?
|
| Transformation, Genetic | 2 | 2000 | 194 | 0.060 |
Why?
|
| Transcription Initiation Site | 1 | 2004 | 189 | 0.050 |
Why?
|
| Biphenyl Compounds | 1 | 2008 | 1026 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1249 | 0.050 |
Why?
|
| Genes, Duplicate | 1 | 2003 | 31 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2007 | 943 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2004 | 204 | 0.050 |
Why?
|
| RNA, Viral | 5 | 1999 | 2866 | 0.050 |
Why?
|
| Polystyrenes | 1 | 2003 | 105 | 0.050 |
Why?
|
| Antigenic Variation | 2 | 2014 | 118 | 0.050 |
Why?
|
| DNA, Single-Stranded | 1 | 2005 | 351 | 0.050 |
Why?
|
| DNA, Recombinant | 4 | 1989 | 455 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 293 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2024 | 393 | 0.050 |
Why?
|
| Plasmodium yoelii | 1 | 2002 | 41 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4570 | 0.050 |
Why?
|
| Iron Radioisotopes | 1 | 2002 | 19 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2004 | 405 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2247 | 0.050 |
Why?
|
| Oxygen | 1 | 2014 | 4273 | 0.050 |
Why?
|
| Feces | 3 | 2016 | 1512 | 0.050 |
Why?
|
| Brazil | 3 | 2007 | 1248 | 0.050 |
Why?
|
| Viral Proteins | 3 | 1980 | 1802 | 0.050 |
Why?
|
| Population Surveillance | 3 | 2021 | 2598 | 0.050 |
Why?
|
| Xenobiotics | 1 | 2022 | 71 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2019 | 1647 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 22355 | 0.050 |
Why?
|
| Siderophores | 1 | 2002 | 61 | 0.050 |
Why?
|
| Africa, Western | 2 | 2011 | 160 | 0.050 |
Why?
|
| Rats | 5 | 2015 | 23835 | 0.050 |
Why?
|
| Recombinant Proteins | 4 | 2009 | 6510 | 0.050 |
Why?
|
| DNA Transposable Elements | 1 | 1985 | 762 | 0.050 |
Why?
|
| RNA, Fungal | 1 | 2002 | 156 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2017 | 26411 | 0.050 |
Why?
|
| Prebiotics | 1 | 2021 | 41 | 0.050 |
Why?
|
| Escherichia coli | 6 | 2008 | 4211 | 0.050 |
Why?
|
| Lac Operon | 1 | 2001 | 237 | 0.050 |
Why?
|
| Young Adult | 9 | 2021 | 60049 | 0.050 |
Why?
|
| Chimera | 2 | 1993 | 454 | 0.050 |
Why?
|
| Leishmania tropica | 2 | 1993 | 8 | 0.040 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2000 | 316 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2004 | 1163 | 0.040 |
Why?
|
| Culture Media | 2 | 2002 | 898 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 3 | 2004 | 1131 | 0.040 |
Why?
|
| Drug and Narcotic Control | 1 | 2001 | 145 | 0.040 |
Why?
|
| Cell Nucleus | 3 | 2012 | 2886 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 542 | 0.040 |
Why?
|
| Fungal Proteins | 2 | 1995 | 906 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2022 | 284 | 0.040 |
Why?
|
| Puromycin | 3 | 1993 | 41 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2015 | 5099 | 0.040 |
Why?
|
| Protein Phosphatase 2 | 1 | 2002 | 231 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2005 | 1186 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 797 | 0.040 |
Why?
|
| Venezuela | 1 | 1999 | 73 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 3779 | 0.040 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2001 | 148 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2000 | 527 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2003 | 773 | 0.040 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 1999 | 21 | 0.040 |
Why?
|
| Viral Fusion Proteins | 1 | 2000 | 100 | 0.040 |
Why?
|
| Incidence | 4 | 2024 | 21544 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 2001 | 1992 | 0.040 |
Why?
|
| Capsid | 2 | 1999 | 435 | 0.040 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2022 | 495 | 0.040 |
Why?
|
| Leishmania braziliensis | 2 | 1990 | 16 | 0.040 |
Why?
|
| Optical Phenomena | 1 | 2019 | 105 | 0.040 |
Why?
|
| Kinetics | 2 | 2009 | 6333 | 0.040 |
Why?
|
| Receptors, Complement | 1 | 2000 | 254 | 0.040 |
Why?
|
| Time | 1 | 2021 | 546 | 0.040 |
Why?
|
| Rural Population | 3 | 2007 | 2318 | 0.040 |
Why?
|
| Organelles | 1 | 2000 | 265 | 0.040 |
Why?
|
| Leishmaniasis, Cutaneous | 2 | 1998 | 137 | 0.040 |
Why?
|
| Haiti | 1 | 2020 | 553 | 0.040 |
Why?
|
| Microcirculation | 1 | 2003 | 1282 | 0.040 |
Why?
|
| Glucuronidase | 1 | 2000 | 205 | 0.040 |
Why?
|
| National Health Programs | 2 | 2011 | 442 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2002 | 1974 | 0.040 |
Why?
|
| Reproducibility of Results | 5 | 2016 | 20224 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 1315 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9562 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2018 | 201 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 1995 | 142 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2019 | 946 | 0.040 |
Why?
|
| Cryptosporidium parvum | 1 | 1997 | 35 | 0.040 |
Why?
|
| Saimiri | 1 | 2018 | 337 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2018 | 540 | 0.030 |
Why?
|
| Probiotics | 1 | 2021 | 383 | 0.030 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2016 | 15 | 0.030 |
Why?
|
| Decision Making | 1 | 2011 | 3953 | 0.030 |
Why?
|
| Mali | 1 | 2016 | 50 | 0.030 |
Why?
|
| Parasite Egg Count | 1 | 2016 | 29 | 0.030 |
Why?
|
| Liberia | 1 | 2017 | 176 | 0.030 |
Why?
|
| Travel | 2 | 2017 | 800 | 0.030 |
Why?
|
| Population Dynamics | 1 | 2018 | 314 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2000 | 738 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2002 | 800 | 0.030 |
Why?
|
| Azabicyclo Compounds | 1 | 2016 | 68 | 0.030 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 59686 | 0.030 |
Why?
|
| Comoros | 1 | 2015 | 12 | 0.030 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2016 | 51 | 0.030 |
Why?
|
| Molecular Weight | 5 | 1985 | 2172 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2019 | 2636 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2008 | 14481 | 0.030 |
Why?
|
| Research Design | 1 | 2011 | 6210 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2016 | 146 | 0.030 |
Why?
|
| French Guiana | 1 | 2015 | 51 | 0.030 |
Why?
|
| Proteins | 1 | 2010 | 6006 | 0.030 |
Why?
|
| Pheromones | 1 | 1995 | 93 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2016 | 267 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4785 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 751 | 0.030 |
Why?
|
| Cell Line, Tumor | 4 | 2016 | 17135 | 0.030 |
Why?
|
| Kanamycin Kinase | 1 | 1994 | 34 | 0.030 |
Why?
|
| Panama | 1 | 2014 | 28 | 0.030 |
Why?
|
| Reticulocyte Count | 1 | 2014 | 36 | 0.030 |
Why?
|
| Transcription Factors | 4 | 2022 | 12166 | 0.030 |
Why?
|
| Cats | 1 | 2016 | 978 | 0.030 |
Why?
|
| Buffers | 1 | 2014 | 143 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2017 | 6234 | 0.030 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2014 | 72 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 8051 | 0.030 |
Why?
|
| Plasmodium knowlesi | 1 | 2014 | 23 | 0.030 |
Why?
|
| Haptoglobins | 1 | 2016 | 165 | 0.030 |
Why?
|
| Hepatitis C Antibodies | 1 | 1995 | 151 | 0.030 |
Why?
|
| 1-Naphthylamine | 1 | 1994 | 48 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 2002 | 1104 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 378 | 0.030 |
Why?
|
| False Positive Reactions | 2 | 1994 | 962 | 0.030 |
Why?
|
| Desipramine | 1 | 1994 | 183 | 0.030 |
Why?
|
| Aged | 9 | 2017 | 171562 | 0.030 |
Why?
|
| Desiccation | 1 | 2014 | 77 | 0.030 |
Why?
|
| Hepatitis C | 2 | 1995 | 1593 | 0.030 |
Why?
|
| Half-Life | 1 | 2015 | 650 | 0.030 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2014 | 91 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2016 | 348 | 0.030 |
Why?
|
| Dogs | 2 | 2011 | 3846 | 0.030 |
Why?
|
| Neutropenia | 1 | 1999 | 893 | 0.030 |
Why?
|
| Malaria, Avian | 1 | 1993 | 2 | 0.030 |
Why?
|
| Colombia | 1 | 2014 | 287 | 0.030 |
Why?
|
| Middle Aged | 10 | 2017 | 223491 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2014 | 657 | 0.030 |
Why?
|
| Biological Availability | 1 | 2014 | 392 | 0.030 |
Why?
|
| Mycobacterium avium Complex | 1 | 1993 | 60 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2015 | 65379 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2018 | 1684 | 0.030 |
Why?
|
| Endolimax | 1 | 1993 | 6 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 1530 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2015 | 1309 | 0.030 |
Why?
|
| Primates | 1 | 2016 | 521 | 0.030 |
Why?
|
| Cytosol | 1 | 2016 | 886 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2015 | 296 | 0.030 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1993 | 76 | 0.030 |
Why?
|
| Hemochromatosis | 1 | 2014 | 176 | 0.030 |
Why?
|
| Substance Abuse, Intravenous | 2 | 1995 | 530 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2013 | 102 | 0.030 |
Why?
|
| Time Factors | 5 | 2015 | 40272 | 0.030 |
Why?
|
| Sertraline | 1 | 1994 | 209 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1197 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 525 | 0.030 |
Why?
|
| Solubility | 1 | 2014 | 1085 | 0.030 |
Why?
|
| Vacuoles | 1 | 2013 | 224 | 0.030 |
Why?
|
| Clone Cells | 1 | 2016 | 1671 | 0.030 |
Why?
|
| Population Density | 1 | 2013 | 193 | 0.030 |
Why?
|
| Tanzania | 1 | 2017 | 1403 | 0.030 |
Why?
|
| Software | 2 | 2018 | 4453 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2019 | 5900 | 0.030 |
Why?
|
| Genetic Association Studies | 2 | 2012 | 2742 | 0.030 |
Why?
|
| Protein Biosynthesis | 3 | 1986 | 2094 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1994 | 434 | 0.020 |
Why?
|
| Viral Nonstructural Proteins | 1 | 1994 | 228 | 0.020 |
Why?
|
| Autopsy | 1 | 2016 | 1013 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2020 | 2505 | 0.020 |
Why?
|
| Safety | 1 | 2016 | 1159 | 0.020 |
Why?
|
| Colchicine | 2 | 1990 | 257 | 0.020 |
Why?
|
| Doxorubicin | 2 | 1995 | 2229 | 0.020 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2011 | 62 | 0.020 |
Why?
|
| Organisms, Genetically Modified | 1 | 2011 | 63 | 0.020 |
Why?
|
| Ligands | 2 | 2009 | 3283 | 0.020 |
Why?
|
| Insect Bites and Stings | 1 | 2011 | 71 | 0.020 |
Why?
|
| Insecticide-Treated Bednets | 1 | 2011 | 70 | 0.020 |
Why?
|
| Uganda | 1 | 2016 | 1351 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 790 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 10267 | 0.020 |
Why?
|
| Confidence Intervals | 2 | 1995 | 2931 | 0.020 |
Why?
|
| Autoradiography | 1 | 1991 | 732 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 1999 | 1883 | 0.020 |
Why?
|
| Filarioidea | 2 | 1987 | 9 | 0.020 |
Why?
|
| Mexico | 1 | 1993 | 767 | 0.020 |
Why?
|
| Fluoxetine | 1 | 1994 | 735 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 1994 | 641 | 0.020 |
Why?
|
| Simuliidae | 1 | 1989 | 5 | 0.020 |
Why?
|
| Insecticides | 1 | 2011 | 200 | 0.020 |
Why?
|
| Dirofilaria immitis | 2 | 1986 | 8 | 0.020 |
Why?
|
| Genome, Viral | 1 | 1994 | 673 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 2433 | 0.020 |
Why?
|
| Nucleotides | 1 | 2012 | 455 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2016 | 2362 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1999 | 2856 | 0.020 |
Why?
|
| Immunity | 2 | 2006 | 1003 | 0.020 |
Why?
|
| Fever | 1 | 2017 | 1620 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 17575 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2017 | 3663 | 0.020 |
Why?
|
| Fosfomycin | 1 | 2009 | 25 | 0.020 |
Why?
|
| Vesicular stomatitis Indiana virus | 2 | 1980 | 93 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2019 | 8326 | 0.020 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2009 | 99 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 13020 | 0.020 |
Why?
|
| Metabolomics | 1 | 2018 | 1674 | 0.020 |
Why?
|
| RNA Viruses | 1 | 1989 | 111 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1994 | 1669 | 0.020 |
Why?
|
| Mice, Inbred C3H | 2 | 1986 | 915 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2533 | 0.020 |
Why?
|
| Tricarboxylic Acids | 1 | 2007 | 26 | 0.020 |
Why?
|
| Bacteriophages | 2 | 1989 | 382 | 0.020 |
Why?
|
| Eukaryota | 1 | 1988 | 101 | 0.020 |
Why?
|
| Health Status | 1 | 2021 | 4094 | 0.020 |
Why?
|
| Sirolimus | 1 | 2015 | 1542 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 2127 | 0.020 |
Why?
|
| Onchocerciasis | 1 | 1987 | 28 | 0.020 |
Why?
|
| Epidemics | 1 | 2013 | 517 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4291 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1999 | 4526 | 0.020 |
Why?
|
| Trypanosoma brucei brucei | 1 | 1986 | 43 | 0.020 |
Why?
|
| Hepacivirus | 1 | 1994 | 1342 | 0.020 |
Why?
|
| Gerbillinae | 1 | 1986 | 87 | 0.020 |
Why?
|
| Collodion | 1 | 1986 | 34 | 0.020 |
Why?
|
| GTP Cyclohydrolase | 1 | 2006 | 47 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 1053 | 0.020 |
Why?
|
| Bacteremia | 1 | 1993 | 985 | 0.020 |
Why?
|
| Rabbits | 2 | 2003 | 4781 | 0.020 |
Why?
|
| Elephantiasis, Filarial | 1 | 1986 | 31 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2012 | 1191 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 2012 | 710 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1986 | 223 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 1839 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2011 | 1561 | 0.020 |
Why?
|
| Leishmaniasis, Visceral | 1 | 1986 | 100 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2012 | 791 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 1748 | 0.020 |
Why?
|
| Sporozoites | 1 | 2005 | 83 | 0.020 |
Why?
|
| Body Composition | 1 | 2015 | 2461 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 1682 | 0.020 |
Why?
|
| Aedes | 1 | 1986 | 101 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 4120 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2022 | 41795 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 4411 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9636 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1989 | 1390 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1989 | 2559 | 0.010 |
Why?
|
| Signal Transduction | 3 | 2019 | 23631 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 2002 | 19022 | 0.010 |
Why?
|
| Karyotyping | 1 | 1986 | 1173 | 0.010 |
Why?
|
| Lung | 1 | 2003 | 10089 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 717 | 0.010 |
Why?
|
| Imidazoles | 1 | 2010 | 1168 | 0.010 |
Why?
|
| Zygote | 1 | 1984 | 115 | 0.010 |
Why?
|
| Skin | 1 | 1998 | 4499 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2008 | 1753 | 0.010 |
Why?
|
| Proteomics | 1 | 2017 | 3906 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2830 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 1990 | 15455 | 0.010 |
Why?
|
| Peptides | 1 | 1995 | 4353 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1984 | 1142 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1998 | 8075 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1982 | 256 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 2002 | 417 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11120 | 0.010 |
Why?
|
| Models, Biological | 2 | 2013 | 9493 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 1986 | 1337 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1999 | 9614 | 0.010 |
Why?
|
| Cross-Sectional Studies | 3 | 2014 | 26375 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2024 | 81801 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39407 | 0.010 |
Why?
|
| Streptomyces | 1 | 1981 | 91 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1981 | 135 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 4646 | 0.010 |
Why?
|
| Polyribosomes | 2 | 1980 | 109 | 0.010 |
Why?
|
| Chromatin | 1 | 2012 | 2968 | 0.010 |
Why?
|
| Phosphoproteins | 2 | 1980 | 2448 | 0.010 |
Why?
|
| Surface Properties | 1 | 2003 | 1167 | 0.010 |
Why?
|
| Agriculture | 1 | 2001 | 187 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1980 | 2846 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2007 | 1815 | 0.010 |
Why?
|
| Health Care Sector | 1 | 2001 | 197 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1986 | 3632 | 0.010 |
Why?
|
| Legislation, Drug | 1 | 2001 | 216 | 0.010 |
Why?
|
| Sheep | 1 | 2002 | 1451 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 1653 | 0.010 |
Why?
|
| Sex Differentiation | 1 | 1999 | 73 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1986 | 9261 | 0.010 |
Why?
|
| Health Priorities | 1 | 2001 | 380 | 0.010 |
Why?
|
| Perfusion | 1 | 2003 | 1402 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1993 | 12558 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 1977 | 66 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2008 | 4177 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 1999 | 343 | 0.010 |
Why?
|
| Asparagine | 1 | 1977 | 120 | 0.010 |
Why?
|
| Mannose | 1 | 1977 | 120 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1979 | 530 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1998 | 363 | 0.010 |
Why?
|
| Pregnancy | 2 | 2011 | 30200 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2006 | 2324 | 0.010 |
Why?
|
| Glycopeptides | 1 | 1977 | 225 | 0.010 |
Why?
|
| Cell Separation | 1 | 2002 | 1726 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2001 | 1093 | 0.010 |
Why?
|
| Cattle | 1 | 2002 | 3826 | 0.010 |
Why?
|
| RNA | 1 | 1986 | 2726 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 560 | 0.010 |
Why?
|
| Rhodamines | 1 | 1995 | 178 | 0.010 |
Why?
|
| Berlin | 1 | 1995 | 23 | 0.010 |
Why?
|
| Molecular Probe Techniques | 1 | 1995 | 111 | 0.010 |
Why?
|
| Needle Sharing | 1 | 1995 | 22 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2003 | 1359 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 1999 | 875 | 0.010 |
Why?
|
| Peru | 1 | 1998 | 890 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 1983 | 1723 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2012 | 11668 | 0.010 |
Why?
|
| Amino Acids | 1 | 2000 | 1716 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1982 | 1084 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2001 | 1407 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 1995 | 405 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3587 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 9343 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1998 | 1627 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 7242 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1980 | 1999 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 1993 | 277 | 0.010 |
Why?
|
| Syphilis | 1 | 1995 | 243 | 0.010 |
Why?
|
| Germany | 1 | 1994 | 882 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8506 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 1629 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1998 | 2205 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2002 | 5313 | 0.010 |
Why?
|
| Daunorubicin | 1 | 1990 | 157 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1990 | 305 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1993 | 1216 | 0.010 |
Why?
|
| Azure Stains | 1 | 1989 | 4 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 18471 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 54920 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1995 | 708 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 1995 | 962 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1977 | 1901 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1990 | 828 | 0.000 |
Why?
|
| United States | 1 | 1996 | 73150 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1995 | 3813 | 0.000 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1989 | 366 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1979 | 3610 | 0.000 |
Why?
|
| Wuchereria | 1 | 1986 | 1 | 0.000 |
Why?
|
| Wuchereria bancrofti | 1 | 1986 | 20 | 0.000 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1986 | 31 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1993 | 1280 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1990 | 1420 | 0.000 |
Why?
|
| Health Services Accessibility | 1 | 2001 | 5512 | 0.000 |
Why?
|
| Endonucleases | 1 | 1986 | 371 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1999 | 3620 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1993 | 5496 | 0.000 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1981 | 20 | 0.000 |
Why?
|
| Logistic Models | 1 | 1995 | 13323 | 0.000 |
Why?
|
| Algorithms | 1 | 2000 | 14154 | 0.000 |
Why?
|
| Intracellular Membranes | 1 | 1980 | 388 | 0.000 |
Why?
|
| Ribosomes | 1 | 1980 | 499 | 0.000 |
Why?
|
| Protein Kinases | 1 | 1980 | 1609 | 0.000 |
Why?
|
| Epitopes | 1 | 1979 | 2525 | 0.000 |
Why?
|
| Risk Factors | 1 | 1995 | 74962 | 0.000 |
Why?
|